A universal vaccine being developed in the UK that should be effective against various strains of the coronavirus may hit the market this year, according to The Daily Telegraph.
Two teams of researchers in the UK are working on vaccines the use of which allows the body's immune system not to recognize the coronavirus protein, whose structure is more susceptible to mutations. The latter change much less frequently, allowing new vaccines to stay effective for longer.
Such drugs are being developed by the University of Nottingham, as well as the private company Scancell, which plans to start clinical trials of its vaccines in the second half of the year in order to get positive results from the respective tests on mice.
Researchers in Belgium, France, the US, and a number of other countries are also working on vaccines that remain effective when new coronavirus strains emerge.